Fig. 2From: Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancerSerum CA125 levels of patients before and after neoadjuvant chemotherapy. *P < 0.01, serum CA125 level between the remission group (33.27±5.03 U/mL) and ineffective group (63.27±5.13 U/mL after 4 courses of neoadjuvant chemotherapyBack to article page